This page and its contents are copyright © 2006 by Etopia Media News Networks. All rights in all media reserved.

packaging of Gardasil®, Merck's anti-HPV vaccine

a vaccine effective against the virus strains responsible for 70% of cervical cancer cases

As reported on July 6, 2006 by Etopia Medical News in an article entitled, "Human papillomavirus (HPV) vaccine Gardasil® on track for inclusion in Vaccine for Children (VFC) program; CDC spokesperson sees no "wave of public sentiment" against this breakthrough treatment for the prevention of cervical cancer," Merck & Co. has successfully developed and is now providing a vaccine effective against the strains of virus responsible for 70% of cervical cancer cases, as well as two strains of genital warts.

an interview with Dr. Rick Haupt, Executive Medical Director, Policy, Public Health and Medical Affairs, Merck Vaccine Division

In order to provide its audience with comprehensive and detailed information about Merck's Gardasil® anti-HPV vaccine, Etopia Medical News spoke this morning with Dr. Rick Haupt, Executive Medical Director, Policy, Public Health and Medical Affairs, Merck Vaccine Division, about this breakthrough in cancer prevention.

You can listen to that interview, in its entirety, by clicking here.

 

Get into the swing of things with additional Etopia Media News Network articles and interviews and Google Alerts

To access additional, recent articles from the Etopia Media News Networks web site, as crawled and cataloged on the Google News web site, click here.

To sign up for Google Alerts whenever a new Etopia Media News Networks article appears on Google News, click here.